Mexiletine
- Generic Name
- Mexiletine
- Brand Names
- Namuscla
- Drug Type
- Small Molecule
- Chemical Formula
- C11H17NO
- CAS Number
- 31828-71-4
- Unique Ingredient Identifier
- 1U511HHV4Z
Overview
Antiarrhythmic agent pharmacologically similar to lidocaine. It may have some anticonvulsant properties.
Background
Antiarrhythmic agent pharmacologically similar to lidocaine. It may have some anticonvulsant properties.
Indication
For the treatment of ventricular tachycardia and symptomatic premature ventricular beats, and prevention of ventricular fibrillation.
Associated Conditions
- Ventricular Arrhythmia
- Ventricular Tachycardia, Sustained
Clinical Trials
FDA Approved Products
Mexiletine Hydrochloride
Manufacturer:AvKARE
Route:ORAL
Strength:250 mg in 1 1
Approved: 2023/05/10
NDC:42291-626
Mexiletine Hydrochloride
Manufacturer:AvKARE
Route:ORAL
Strength:150 mg in 1 1
Approved: 2023/05/10
NDC:42291-624
MEXILETINE HYDROCHLORIDE
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:150 mg in 1 1
Approved: 2021/11/22
NDC:72162-1782
Mexiletine Hydrochloride
Manufacturer:Lannett Company, Inc.
Route:ORAL
Strength:200 mg in 1 1
Approved: 2020/08/24
NDC:0527-4108
Mexiletine hydrochloride
Manufacturer:Camber Pharmaceuticals, Inc.
Route:ORAL
Strength:150 mg in 1 1
Approved: 2022/11/16
NDC:31722-036
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath